Pandemic Demand Forces Rapidly Increased Production And Expertise
Source: Cytiva

To combat COVID-19, the life sciences industry rapidly changed its pace. Solis BioDyne, one of the leading reagent suppliers in Europe, manufactures PCR/qPCR reagents and specifically a ribonuclease inhibitor used for COVID-19 RT-qPCR diagnostic tests. Previously manufactured at bench scale, the company now needed to quickly increase production 50-fold to meet the demand of COVID-19 tests. Solis BioDyne faced two challenges: safely producing this large volume and maintaining a very high quality.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more